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Abstract
Background: Glutathione is considered essential for survival in mammalian cells and yeast but not in prokaryotic cells. The
presence of a nuclear pool of glutathione has been demonstrated but its role in cellular proliferation and differentiation is
still a matter of debate.
Principal Findings: We have studied proliferation of 3T3 fibroblasts for a period of 5 days. Cells were treated with two well
known depleting agents, diethyl maleate (DEM) and buthionine sulfoximine (BSO), and the cellular and nuclear glutathione
levels were assessed by analytical and confocal microscopic techniques, respectively. Both agents decreased total cellular
glutathione although depletion by BSO was more sustained. However, the nuclear glutathione pool resisted depletion by
BSO but not with DEM. Interestingly, cell proliferation was impaired by DEM, but not by BSO. Treating the cells
simultaneously with DEM and with glutathione ethyl ester to restore intracellular GSH levels completely prevented the
effects of DEM on cell proliferation.
Conclusions: Our results demonstrate the importance of nuclear glutathione in the control of cell proliferation in 3T3
fibroblasts and suggest that a reduced nuclear environment is necessary for cells to progress in the cell cycle.
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Introduction
Oxidative stress is able to modulate cell growth [1,2] and it was
traditionally defined as the prevalence of the reactive oxygen species
(ROS) over antioxidants [3]. Nowadays, a new definition is
proposed: disruption of redox signalling and control [4]. This takes
into account the signalling role of ROS that emerges in many
physiological processes, includingcell proliferation. Classical reports
by Oberley and Davies showed that mild extrinsic oxidative stimuli,
such as superoxide and hydrogen peroxide, could activate signalling
pathways leading to proliferation [1,5]. Subsequently, it was shown
that a low level of ROS is necessary for the correct mitogenic
signalling [6]. The later finding that an oxidation event early in G1
phase is a critical regulatory step in the progression to S phase, lead
to the development of the model of redox cycle within the cell cycle;
the transient change in ROS could modify the redox state of cell
regulatory proteins at their critical cysteine residues and thus
determine the progression or arrest in the proliferation [7,8].
However, little information has been provided on the active role
of glutathione and other powerful antioxidant cellular defense
mechanisms during the cell cycle.
A number of seminal previous reports must be considered. Early
studies suggested the role of low molecular weight thiols in the cell
proliferation [9], and point to the level of GSH as an important factor
in the control of the tumour growth [10]. Nevertheless, it was only
relatively recently when the group of Dean Jones defining the cellular
redox environment by estimation of the ratio of glutathione/
glutathione disulfide couple concluded that each phase in the life of
the cell is characterized by a particular redox state and that
proliferating cells are in a most reduced state [11]. In general, the
elucidation of the role of GSH in the cell proliferation was approached
by the determination of its overall cellular content, although it is the
nucleus where most cell cycle progression events take place.
The study of nuclear compartmentalization of GSH poses a
significant methodological challenge and the findings were
controversial over the last decade. Pioneer work by Bellomo et
al. [12] using monochlorobimane-GSH conjugation demonstrated
an important nuclear compartmentalization of GSH in hepato-
cytes. However, a report by Briviva et al. [13] on microinjection
studies performed with various fluorochromes, including mono-
chlorobimane, showed that GSH conjugates can preferentially
localize to nuclei [13]. In addition, nuclear pores do not restrict
diffusion of low molecular weight solutes like GSH [14], which
could possibly difficult the establishment of a specific pool of GSH
within the nucleus. Several studies have shown that glutathione
related enzymes like GSH S-transferase (GST) and GSSG
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cytoplasm [15]. For instance of the 8 reported isoforms of GST
two of them have been found in the nucleus according to different
authors [16,17]. Although other report denied the presence of any
GST activity in the nucleus [18] various reports [19,20] including
a recent work by Stella et al. [21] clearly showed that at least a-
GST isoform is present, both inside the nucleus and in the outer
nuclear membrane, suggesting that GST plays a major protective
role in the nucleus against alkylating compounds and organic
peroxides. Apart from glutathione, another physiological reducing
agent in the nucleus, thioredoxin-1 and other related systems also
redistribute between nuclei and cytoplasm creating a protective
reduced environment within the nucleus. A recent report by
Gutscher et al. [22] provides a new and valuable tool to study the
glutathione redox state in cells. Although the method is restricted
to cytosol and mitochondrial compartments, this kind of
methodology can provide a better insight in the redox state of
the different cellular compartments during cell proliferation.
In a series of previous reports we showed that cells have high
GSH levels when they proliferate, and cellular GSH levels
correlate positively with telomerase activity [23,24]. When we
characterized the distribution of GSH within the cell [24], a
nucleus:cytoplasm (N/C) ratio higher of 4/1 was shown in 3T3
fibroblasts during the early phases of cell proliferation. The N/C
ratio decreased to 1/1 when cells reached confluence, i.e. when
most cells were in the G0/G1 phase of the cell cycle, suggesting
that cells need a reduced nuclear environment to proliferate.
GSH concentration can be selectively decreased in vivo by
various methods, e.g. by buthionine sulfoximine (BSO) which is a
transition state inactivator of glutamate cysteine ligase (GCL) that
catalyzes the first limiting step of GSH synthesis. Alternatively, it
can be inhibited by non-specific agents: diamide (a thiol-oxidizing
agent), N-ethylmaleimide (a thiol-alkylating compound) and
butylhydroperoxide [25]. Diethylmaleate (DEM) also decreases
intracellular GSH concentration through a reaction catalyzed by
the enzyme glutathione-S-transferase [26].
The aim of this work was to clarify the importance of nuclear
GSH in cell proliferation. Cells were treated with BSO or DEM.
These agents decrease GSH levels by two different means; BSO
decreases GSH synthesis and DEM, a weak electrophile forms
DEM-GSH adducts, although DEM may not be absolutely
specific to GSH [27]. We found that DEM but not BSO
decreased nuclear GSH and impaired cell proliferation. We show
for the first time that cellular proliferation specifically relates with
nuclear, but not with total cellular GSH levels. The results
underscore the importance of maintaining a reduced nuclear
environment in order to maintain normal cell cycle progression.
Materials and Methods
Cell Culture
3T3 fibroblasts were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% foetal calf serum (Invitrogen,
San Diego, CA, USA) and antibiotics (25 U/ml penicillin, 25 mg/
ml streptomycin, and 0.3 mg/ml amphotericin B) (Invitrogen, San
Diego, CA, USA) in 5% CO2 in air at 37uCi n2 5o r7 5c m
2 flasks.
Glutathione depletion
3T3 fibroblasts were plated as previously described [24] and
after attaching to the plate (3 h) GSH levels were manipulated by
one of the following mechanisms:
– Incubation with 100 mM diethylmaleate (DEM) (Sigma-
Aldrich, St. Louis, MO, USA);
– Incubation with 100 mM DEM and 1 mM glutathione ethyl
ester (GSHe) (Sigma-Aldrich, St. Louis, MO, USA);
– Incubation with 10 mM Butionine sulfoximine (BSO) (Sigma-
Aldrich, St. Louis, MO, USA)
Enzymatic determination of reduced glutathione
Cultured fibroblasts were washed with PBS and extracts were
obtained in 6% perchloric acid (PCA) containing 1 mM EDTA.
GSH was measured spectrophotometrically using the glutathione-
S-transferase assay [28].
Cell cycle Analysis by Flow Cytometry
Cell cycle phases were determined by the estimation of the
DNA content using propidium iodide (PI) staining and flow
cytometry analysis [29,30].
Fixation: Cells were collected by trypsinization and counted.
The pellet was fixed in ice cold 96% ethanol (1610
6 cells/2 ml
ethanol). Samples were stored at 220uC until analysis.
Staining: Ethanol fixed cells were washed twice with PBS at room
temperature and incubated for 1 h at room temperature in the
staining solution that contained: 50 ml propidium iodide (1 mg/ml)
(Sigma-Aldrich, St. Louis, MO, USA), 50 ml IGEPAL (1:10) (Sigma-
Aldrich, St. Louis, MO, USA) 25 ml RNAse (10 mg/ml) (Sigma-
Aldrich, St. Louis, MO, USA) and 875 mlo fP B Sp e r1 610
6 cells.
Analysis was performed using an EPICS ELITE cell sorter
(Coulter Electronics, Miami, FL, USA). Propidium iodide was
excited with an argon laser tuned at 488 nm. Forward-angle and
right-angle light scattering were measured. Samples were acquired
for 15,000 individual cells. Cell cycle phases and cell death were
determined at 630 nm fluorescence emission [24].
Confocal microscopy
Confocal images were acquired using a Leica TCS-SP2
confocal laser scanning unit equipped with argon and helium-
neon laser beams and attached to a Leica DM1RB inverted
microscope (Leica Microsystems, Mannheim, Germany).
3T3 fibroblasts were maintained in culture as described
previously [24] and plated in 2 cm
2 LAB-TEK II chambered
cover glass (Nunc, Thermo Fischer Scientific, Waltham, MA,
USA) for 5 days, 72 h, 48 h, 24 h, and 6 h before the experiment
and treated after attaching as explained before. All treatment
conditions and controls were dyed and analyzed on the same day.
Double staining was performed: 2 mg/ml Hoechst (Sigma-Aldrich,
St. Louis, MO, USA) to localize nuclei and 5 mM green 5-
chloromethyl-fluorescein diacetate (CMFDA) (Invitrogen, San
Diego, CA, USA), to detect GSH (specificity 95%) [31]. Cells
were first stained with 5 mM CMFDA in cell culture medium for
30 min., at 37uC and 5% CO2. After washing with pre-warmed
cell culture medium, cells were left to rest for 30 min at 37uC and
5% CO2, in cell culture medium. In the last 5 min of incubation
2 mg/ml Hoechst (Sigma-Aldrich, St. Louis, MO, USA) was
added. After incubation with the fluorochromes, staining solution
was replaced with fresh pre-warmed cell culture medium and cells
were analyzed. Cell washing procedures did not change
glutathione distribution (result not shown).
The excitation wavelengths for fluorochromes were 488 nm for
CMFDA, and 364 nm for Hoechst. Fluorescence detection was
510–540 nm for CMFDA, and 380–485 for Hoechst.
Quantification of the fluorescence emission by area
Perimeters were drawn around the nuclei following the area
marked with Hoechst, and the mean of nuclear CMFDA
DEM Depletes Nuclear GSH
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experiments). Similarly, the mitochondria area was defined by
high perinuclear CMFDA fluorescence, as reported previously
[24]. The cellular area was defined by the transmission image and
the perimeter that defines cytoplasm was drown around the cell
membrane excluding the nuclear area.
Immunoblot analysis of cell cycle proteins
Equal amounts of protein (10–15 mg) were boiled in sample
buffer for 5 min and separated by SDS/PAGE. After electropho-
resis, the proteins were transferred to 0.2-mm-pore-size nitrocel-
lulose membrane. Membranes were incubated in blocking solution
[5% (w/v) non-fat dry milk in TTBS [25 mM Tris/HCl (pH 7.5)/
0.15 M NaCl/0.05% (v/v) Tween 20], for 1 h at room
temperature with shaking; blots were incubated with rabbit
primary antibody anti-Id2 (c-20) (Santa Cruz Biotechnology,
CA, USA), diluted 1:750 in 1% (w/v) non-fat dry milk TBS-
Tween (TTBS) overnight at 4uC, or with a tubulin (Santa Cruz
Biotechnology, CA, USA), diluted 1:1000 in 1% (w/v) non-fat dry
milk TTBS overnight at 4uC with shaking. Blots were washed
three times with 1% (w/v) non-fat dry milk TTBS and incubated
with the secondary antibody (rabbit for Id2 and mouse for a
tubulin) diluted in 1% non-fat dry milk TTBS conjugated to
horseradish peroxidase (Santa Cruz Biotechnology, CA, USA) for
60 min at room temperature. Finally, blots were washed during 5
minutes three times with TTBS and detection was carried out
using ECL Western blotting detection reagent (Amersham, GE
HealthcareBio-Sciences AB, Uppsala, Sweden). The intensity of
the bands was quantified using an Image J 1.34S (Wayne
Rasband, Image J. 1.34, National Institute of Health, USA), and
the relative Id2/a tubulin band intensity was calculated.
Immunoblot analysis of oxidized and glutathionylated
proteins
To measure the level of nuclear protein oxidation 10 mgo f
nuclear lysates were derivatized, and the western blotting was
performed according to the recommendation of the manufacturer.
The level of nuclear protein oxidation was determined by the Oxy
Blot protein Oxidation Detection Kit (Intergen Company,
Burlington MA, USA) which detects carbonylated proteins.
To obtain nuclear lysate, cells were collected using cellular lysis
buffer (5 mM HEPES pH 8.0, 5 mM KCl, 0.5% v/v IGEPAL) on
ice during 15 min. and then centrifuged at 1000 rpm. 5 min at
4uC. The pellets were resuspended in nuclear lysis buffer (50 mM
Tris HCl pH 8.1, 10 mM EDTA, 1% w/v SDS). Nuclear lysates
were obtained in absence of reducing agents.
To determine oxidized proteins carbonyl groups were deriva-
tized to 2,4-dinitrophenilhydrazone (DNP-hydrazone) by its
reaction with 2,4-dinitrophenilhidrazine (DNPH). The derivatized
samples were separated by electrophoresis in an acrilamide gel
followed by western blotting and immunodetection protocols as
described previously.
To determine glutathionylated proteins western blotting of
nuclear extract were performed as usual, using 10 mg of nuclear
protein. Addition of any reducing agents was avoided. Membrane
was blocked in 5% (w/v) non-fat dry milk in TBST for 1 h at room
temperature, and probed against the anti-glutathione antibody
(Virogen, Grater Boston, MA, USA) at the dilution of 1:1000 in
1% (w/v) non-fat dry milk TTBS over night at 4uC, and secondary
antibody, goat anti-mouse IgG (Calbiochem, San Diego, CA,
USA) conjugated to horseradish peroxidase, at 1:7500 in 1% (w/v)
non-fat dry milk for 1 h at room temperature. Detection
procedure was performed using Amersham RPN 2106 ECL
Western Blotting Detection Reagent (GE HealthcareBio-Sciences
AB, Uppsala, Sweden).
Determination of glutathione S-transferase and
glutathione reductase activity
To obtain cellular extract we collected the cells with 25 mM
glicil-glicine pH 7.4, 150 mM ClK, 5 mM MgSO4,5 m M
EDTA-Na2,1 0m Mb-mercaptoethanol. Cell were subjected to
freeze-thaw cycles (frozen in liquid nitrogen and thawed at 37uC)
to obtain the cell lysate. After centrifuging the cells at 13000 rpm,
for 15 min. at 4uC, enzyme activities in the supernatant were
determined. Glutathione S-transferase activity was measured as
described by Habig et al. [32]. and glutathione reductase as
described by Massey and Williams [33].
Statistics
Results are expressed as mean6SD. The statistical analysis was
performed by the least-significant difference test using an analysis
of variance (ANOVA). The null hypothesis is accepted for all
numbers of those set in which F is non-significant at the level of
p#0.05.
Results
Diethyl maleate impairs cell growth
Control 3T3 fibroblasts grew slowly during the first 6 hours in
culture and then started to grow faster during 48–72 hours. By day
5 of culture cells reached its confluence limit and stopped growing
(see figure 1). Fibroblasts incubated with 10 mM BSO exhibited a
rate of growth similar to that of controls, even growing for a longer
time than untreated cells (day 5 of culture). However cells treated
with DEM 100 mM showed a very low growing profile. Five days
after plating, less than 1.5610
6 cells were present in the culture
dish (250,000 cells were plated) compared with more than 2610
6
in the untreated group. When DEM-treated cells were co-
incubated with 1 mM glutathione ethyl ester (GSHe), to replenish
GSH levels, cells grew at a similar rate as controls.
Depletion of cellular glutathione concentration during
cell proliferation
Cellular glutathione concentration fell progressively during the
culture (as previously reported, in reference [24]). Incubation with
DEM caused a marked and immediate decrease in GSH which was
followed by a considerable over-shooting at 48 h of culture (see
figure 2). Treatment with BSO decreased significantly the GSH
level at 24 h of culture, which augmented towards 72 h, but the
levelspersistedsignificantlylowerthan control.However,when cells
were incubated with DEM and GSH-ester, glutathione levels were
maintained similar to control (no depletion and no over-shooting).
Changes in nuclear glutathione induced by DEM
We studied the distribution of cellular GSH between cytoplasm
and nucleus at different times of culture (6, 24, 48 and 72 hours).
Figure 3 depicts untreated fibroblasts during 24 hours in culture
showing that GSH (CMFDA staining-green fluorescence) co-
localizes with DNA (Hoechst staining-blue fluorescence). Howev-
er, cells incubated with 100 mM DEM showed a homogeneous
GSH distribution within the cells. Surprisingly, inhibition of GSH
synthesis by BSO was unable to change the distribution of cellular
GSH, showing a cellular glutathione pattern different from the one
shown in the DEM-treated cells. Indeed, GSH was high in the
nucleus and low in the cytoplasm, like in the control group. Thus,
each GSH-depleting agent induces different responses in the
DEM Depletes Nuclear GSH
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Co-incubating the cells with 100 mM DEM and 1 mM GSHe
showed similar glutathione distribution to untreated cells.
Quantification of the fluorescence emission in the nuclear and
in the cytoplasmic area is shown in Figure 4. Panel A shows
nuclear CMFDA fluorescence at different time points in untreated,
DEM, DEM+GSHe and BSO treated 3T3 fibroblasts. Clearly
DEM treated fibroblasts at 6, 24 and 48 hours show lower
fluorescence intensity than controls. In those cells incubated with
BSO, CMFDA staining was similar or even higher than in control.
Replenishment of GSH with glutathione monethyl ester showed
nuclear CMFDA distribution similar than untreated cells. Thus,
DEM but not BSO is able to maintain low nuclear GSH levels at
6, 24 and 48 hours of incubation.
The mean cytoplasmic CMFDA fluorescence is much lower
than in the nucleus due to the extension of its surface. In addition,
variability of CMFDA fluorescence is higher due to the variability
in the cytoplasmic area. It was shown that both DEM and BSO
induced a decrease in cytoplasmic CMFDA fluorescence at
24 hours of culture (figure 4B). No significant changes could be
found in the other cell conditions tested; this is probably due to the
high CMFDA fluorescence in the perinuclear area, which could be
explained by the fact that BSO, at the concentrations used in this
work, is unable to deplete mitochondrial GSH [34,35]. Indeed, the
determination of the perinuclear mitochondrial CMFDA staining
after co-localization with mitotracker red (as described previously
[24]) (figure 4C) in 3T3 fibroblasts at 24 hours of culture show that
BSO treated cells maintained a high mitochondrial CMFDA
staining but cytosolic fluorescence was indeed decreased by BSO.
Effect of nuclear GSH depletion on cell growth
Plotting cell growth curves against nuclear CMFDA fluorescence
shows than in control fibroblasts nuclear GSH distribution is
maximal during cell proliferation (figure 5A). However, in DEM
treated cells (figure 5B) nuclear CMFDA fluorescence is lower than
in control cells and DEM attenuates and postpones the nuclear
GSH peak that takes place during cell proliferation. In BSO treated
cells (figure 5C) nuclear CMFDA staining remains high during the
time of culture, as high as in untreated fibroblasts, showing a
proliferation curve very similar to the one shown in controls.
Changes in cell cycle induced by DEM but not by BSO
Figure 6 (A and B) shows the changes in the percentage of cells in
the different phases of the cell cycle during the time of culture. As
Figure 1. Comparison of the effect of GSH depletion by DEM and BSO on cell growth. Cells were plated and after attaching, treated with
100 mM DEM, or 10 mM BSO, or 100 mM DEM+1 mM GSHe. At 6 h, 24 h, 48 h, 72 h, and 5 days of culture cells were detached by trypsinization and
counted. The proliferation curves are created on the basis of the mean6SD of 6–16 different experiments.
doi:10.1371/journal.pone.0006413.g001
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cell cycle was higher when cells were growing, i.e. at 24, 48 and
72 hours in culture. But at the beginning of the culture, when cells
were plated (6 hours) and when they were confluent (day 5), most
cells were in the G0/G1 phase of the cell cycle. However, in cells
that weretreated withDEM the percentage of cells in eitherphase S
or G2/M was lower when cells were proliferating (24–48 hours of
culture) than in controls. As expected BSO and DEM+GSHe
treated cells showed results similar to control fibroblasts.
Changes in cell proliferation are not due to changes in
cell death
The different growing behavior in glutathione depleted cells
(with DEM) was not due to an increased rate of cell death
(figure 6C). Indeed, the percentage of dead cells (necrotic+apop-
totic cells according to the DNA content analysis) in DEM and
BSO treated cells remained low during the first 3 days in culture.
Only during the fifth day of culture i.e. when control and
DEM+GSHe treated cells reached confluence, an increase in the
number of dead cells occurred, but not in the DEM and BSO
treated cells. Thus, as stated above, the difference in the growing
profile between the two depleting agents, DEM and BSO, was not
due to changes in the number of dead cells.
Role of nuclear glutathione in the regulation of cell cycle
In order to find a molecular explanation for the differences in
the rate of growth found when glutathione levels were depleted
with DEM, we studied the expression of the cell cycle-related
protein Id-2 (inhibitor of DNA binding 2). Figure 7 shows that Id-2
expression decreased in the DEM, but not in the BSO treated cells
or in the DEM+GSHe treated cells. Thus, depletion of nuclear,
but not cytoplasmic glutathione levels is able to decrease Id-2
expression, impairing cell growth.
Effect of glutathione depletion on Glutathione S-
Transferase and Glutathione reductase activities
In view of the major changes induced DEM but not BSO on cell
proliferation we determine GST and GR activity in 3T3
fibroblasts (table 1 and table 2, respectively, supplementary data).
However both enzymatic activities assayed at two different time
points (24 hours and 5 days after plating) showed no differences
between control and cells depleted of GSH with either BSO or
Figure 2. GSH depletion in 3T3 fibroblasts. The total cellular GSH concentration was assessed. The cells were plated as described
previously (4) and after attaching 100 mM DEM, or 10 mM BSO, or 100 mM DEM+1 mM GSHe were added. The total cellular concentration of GSH was
determined spectrophotometrically as described in ‘‘Materials and Methods’’. The results are presented as mean6SD of 5–12 different experiments.
doi:10.1371/journal.pone.0006413.g002
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DEM but not by BSO are not caused by variations in the activities
of these two important enzymes of glutathione metabolism.
Role of nuclear glutathione in proliferating 3T3
fibroblasts; the effect on the protein redox state
In order to study the changes that take part during the short
period when GSH is depleted that is not reversed thereafter, we
addressed a kinetic assessment of oxidized and glutathionylated
nuclear proteins in DEM treated cells versus control. As presented
in figure 8 A at 6 and 24 h in culture the fibroblasts showed a
sustained decrease in the pattern of nuclear glutathionylated
proteins. However, in those cells incubated with DEM that were in
culture for 6 days glutathionylation of nuclear proteins increased
to values even higher than controls or BSO treated cells. In BSO
treated cells the expression of nuclear glutathionylated proteins
was similar to controls.
In a similar fashion, the expression of nuclear oxidized proteins
was higher when the nuclear GSH was depleted with DEM, with a
striking difference at 6 hours of culture, when the nuclear GSH
Figure 3. The GSH distribution after its depletion with DEM and BSO. The cells were plated as usual and after attaching, 100 mM DEM, or
10 mM BSO, or 100 mM DEM+1 mM GSHe were added. At 24 h after plating the cells were stained as described in Materials and Methods and
observed by confocal microscopy in the chamber provided with 5% CO2 and at 37uC. Images were taken by light microscopy (transmission) and by
confocal microscopy, as described in Materials and Methods, to capture blue fluorescence of nuclei (Hoechst-nuclei), green fluorescence that marks
GSH (CMFDA-GSH) and red fluorescence of dead cells (PI-dead cells) (results not shown). Z series of at least 8 planes were obtained and maximum
projection images were created and analysed. The representative experiment (of five) is presented.
doi:10.1371/journal.pone.0006413.g003
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have increased oxidized nuclear proteins at day 6 of culture. Thus,
protein carbonyl levels did not rebound as glutathionylated
proteins. Results show that the depletion of cytosolic GSH with
BSO does not affect the redox state of the nucleus, when BSO is
used at low concentration (10 mM). However, 100 mM DEM is
able to deplete both cytosolic and nuclear glutathione, creating a
nuclear environment prone to oxidation.
Figure 4. The effect of DEM and BSO treatment on the nuclear and cytoplasmic pool of GSH. The maximum projection images (as
presented in the fig. 3) were analysed by area, as described in ‘‘Materials and Methods’’. CMFDA fluorescence in nuclear area (defined by Hoechst
staining, see fig. 3) is presented in fig. 4A and the CMFDA fluorescence of the cytoplasm area (defined by transmission images, see fig. 3) is presented
at fig. 4B. The results are mean values of at least 4 different experiments (50–100 cells per experiment). The level of CMFDA fluorescence in the
nuclear, cytoplasmic and mitochondrial area after treatment with BSO and DEM at 24 h of culture is presented at the panel C. The analysis of nuclear
and cytoplasmic area was performed as described. Mitochondrial area was considered to be marked by perinuclear green fluorescence, as
demonstrated previously (4). The results are presented as mean of 3–5 different experiments.
doi:10.1371/journal.pone.0006413.g004
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BSO on the cell growth are shown on the panel B and C, respectively. Control cells are presented at the panel A. The mean CMFDA fluorescence in
nuclear area (defined by Hoechst staining, see fig. 3) was obtained as described in materials and methods, and the profile of the cell growth was
characterized by cell number. The results are presented as mean values of at least 4 experiments.
doi:10.1371/journal.pone.0006413.g005
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last for no more than 3 days and at day 6 DEM treated cells show
a profile of glutathionylated proteins similar to controls, although
nuclear carbonyls remain higher in cells incubated with DEM.
Discussion
Cell proliferation is regulated by a variety of mechanisms
working to allow the activation and repression of growth
Figure 6. Effect of nuclear GSH depletion by DEM and BSO on cell cycle. Cells were plated and treated as described previously. The cell cycle
was studied by flow cytometry, using the level of the fluorescence of the DNA dye propidium iodide (final concentration, 5 mg/mL) at 630 nm
fluorescence emission as a measure of the DNA content per cell, as described in materials and methods. The cells were detached, fixed in ethanol and
stained along the proliferation curve of the 3T3 fibroblasts. The histograms corresponding to each experimental group at 6 h, 24 h, 48 h, and 5 days
of culture (of the same representative experiment) were overlaid and presented at the panel A. The effect of the GSH depletion on the cell
proliferation, defined by mean percentages of cells in phases S+M/G26SD, is presented at the panel B, and the effect of the depletion on the cell
death, i.e. the percentage of apoptotic and necrotic cells is shown on the panel C. The results presented are mean6SD of 5–17 different experiments.
doi:10.1371/journal.pone.0006413.g006
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regulation of growth control genes. Previous in vitro reports show
that the activity of these transcription factors is related to its redox
environment. In addition, change in the redox potential could
induce variations in the activity of those transcription factors.
Alterations as small as615 mV in the redox potential can result in
transcription factor translocation and activation or deactivation,
depending on the direction of the redox shift [36,37,38]. In the
present report nuclear oxidized proteins increase when cells are
depleted of nuclear glutathione due to DEM action. The change in
the nuclear redox environment induced by DEM could activate a
shift in the activity of transcription factors that modulate cell cycle
as we have demonstrated here with the decreased expression of Id2
in DEM treated cells.
Figure 7. The expression of the cell proliferation marker, Id2, after the depletion of the GSH. The cells were plated as usual and after
attaching, 100 mM DEM, or 10 mM BSO, or 100 mMD E M +1 mM GSHe were added. The protein extracts were obtained at 6 h, 24 h, and 72 h of culture
andwestern blotting was performed as described in materialsandmethods. At upper panel, western blot analysis of Id2and b-tubulin in 3T3 fibroblasts
at 6, 24, and 72 h of culture is shown. Lower panel shows the relative Id2 to b-tubulin band intensity [Mean6SD (n=4)] derived from densitometry.
doi:10.1371/journal.pone.0006413.g007
Table 1. Effect of glutathione depletion on Glutathione S-
Transferase (GST) activity.
Time of culture Category GST mU/mg prot. SD
24 h control 0,313 0,057
24 h DEM 0,473 0,077
24 h BSO 0,398 0,074
6 days control 0,656 0,047
6 days DEM 0,715 0,034
6 days BSO 0,533 0,256
The 3T3 fibroblasts were treated with 100 mM diethylmaleate (DEM) or with
10 mM buthionine sulfoximine (BSO) immediately after attaching. The activity of
the GST was determined at 24 h and 6 days of culture, as described in Materials
and methods.
doi:10.1371/journal.pone.0006413.t001
Table 2. Effect of glutathione depletion on Glutathione
reductase (GR) activity.
Time of culture Category GR mU/mg prot. SD
24 h control 0,071 0,003
24 h DEM 0,067 0,003
24 h BSO 0,089 0,000
6 days control 0,093 0,012
6 days DEM 0,111 0,003
6 days BSO 0,112 0,004
The 3T3 fibroblasts were treated with 100 mM diethylmaleate (DEM) or with
10 mM buthionine sulfoximine (BSO) immediately after attaching. The activity of
the GR was determined at 24 h and 6 days of culture, as described in Materials
and methods.
doi:10.1371/journal.pone.0006413.t002
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cell proliferation
Since glutathione is the most important redox regulatory factor
[39], a number of reports have focused on the consequences of the
depletion of cellular glutathione levels on changes in cellular
proliferation [40,41]. However, all those reports were performed
measuring cellular or total glutathione levels, but there is no
information relating cellular proliferation with nuclear glutathione
levels. A number of studies have indicated the existence of a
nuclear GSH pool that resists depletion after exposure of cells to
BSO (for a review see [42]. However, Thomas et al. [43] showed
that depletion of GSH with N-ethyl maleimide or DEM decreased
mercury orange fluorescence in the nucleus and cytoplasm to a
similar extent. By contrast, mercury orange fluorescence in the
Figure 8. The pattern of overall S-glutathionylated and oxidized nuclear proteins induced by the two GSH depleting agents at 6 h,
24 h and 6 days in culture. A.- Glutathionylated proteins: equal amount of nuclear extracts were loaded and separated by a 12% SDS gel under non-
reducing conditions. S-glutathionylated proteins were detected by Western blot using anti-glutathione monoclonal antibody. B.- Oxidized proteins:
equal amounts of nuclear extracts were derivatized and separated by electrophoresis in an acrilamide gel. Western blotting and subsequent
immunodetection of carbonylated proteins were performed according to the protocol recommended by the manufacturer (see material and methods).
Right panels shows the densitometry results for the level of glutathyolation and oxidation of nuclear proteins, respectively [Mean6SD (n=3)].
doi:10.1371/journal.pone.0006413.g008
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the cytoplasm. Spyrou and Holmgren [44] showed that inhibition
of glutathione synthesis by 0.1 mM BSO was able to decrease
GSH synthesis after treatment for 12 hours, but GSH-depleted
cells grew as well as control 3T6 cells with no decrease in DNA
synthesis. Thus, incubation of cells with low concentration of BSO,
although it decreases glutathione levels, does not change cell
proliferation. Esposito et al. [45] showed that DEM treatment
induces cell cycle arrest that is accompanied by several redox-
dependent changes in cell-cycle related proteins. Precisely, the
p53-independent accumulation of p21 was detected. These
authors demonstrated that DEM treatment strongly activates
p21 showing a clear inhibition of cell proliferation.
In the present report we provide for the first time information
on the comparison of changes in the distribution of GSH in the
cell nucleus during cell cycle using the two depleting agents DEM
and BSO. Other authors have provided isolated information on
the role of BSO or DEM or have described their effect on cell
proliferation. However, here we present a comprehensive view,
and a possible explanation, for the different proliferative results
shown by these two well-known GSH depleting agents
Results presented in Fig. 2 show that inhibition of glutathione
synthesis by BSO causes the lasting glutathione decrease strating
from 24 h of culture; on the other hand, the effect of DEM is
instantaneous with an important rebound effect at 48 and
72 hours. The rebound effect was previously reported by Borroz
et al. [42] These authors have shown that partial depletion of GSH
with either phorone or DEM results in a four- to five-fold increase
in hepatic gamma glutamyl cysteinyl synthetase RNA levels.
DEM is an alkylating agent but the effect induced on cell
proliferation is not due to its alkylating properties since incubation
of DEM and GSHe prevented DEM impairment of cell
proliferation.
Here we demonstrate that inhibition of glutathione synthesis by
BSO induces a strong decrease in total GSH levels, but the nuclear
GSH pool was preserved (Fig. 3. and 4.). Similar results have also
been shown by Britten et al. [46]. By contrast, depletion of
glutathione levels by DEM induces a marked decrease in nuclear
glutathione levels. These differences in glutathione depletion
compartmentalization could explain the reported differences in the
inhibition of cell proliferation, shown in Fig. 1. In fact, our results
show that inhibition of glutathione levels by DEM strongly impairs
cell proliferation. This difference could be due to the fact that
DEM decreases both nuclear and cytosolic glutathione levels in
opposition to BSO, which only decreases cytosolic glutathione as it
is shown in figure 4C. Indeed, the Fig. 5 represents the relationship
between nuclear GSH kinetics and the rhythm of cell growth in
the control cells, cells treated with DEM and cells treated with
BSO (Fig. 5 A, B and C, respectively). As demonstrated, the
depletion of nuclear glutathione severely affects cell growth.
Furthermore, the high level of nuclear glutathione is necessary for
the exponential phase of the cell growth: these parameters coincide
in control cells at 24 and 48 h, and the growth slows at 72 h when
the nuclear GSH level is lower; in DEM treated cells the growth is
delayed until the higher level of nuclear GSH is reached, which
occurs at 48–72 h, while in the BSO treated cells the maintained
high level of nuclear GSH between 48 h–72 h results in a
prolonged cell growth when compared to control.
We should however point out an apparent contradiction
between the results shown using CMFDA and those in figure 2,
since the reported decrease in cellular GSH concentration in BSO
treated cells, thus not correspond with major changes when the
GSH distribution was analyzed by the fluorochrome CMFDA
(figure 3,4 and 5). This is due to the fact that the software measures
the mean fluorescence value within a designed surface. The size of
cells varies during the time of incubation. Cells are small when
sided, and then when they grow its cytoplasm spreads in the plate.
Later when cells are confluent the size of the cytoplasm shrinks due
to the number of neighboring cells. The problem thus not apply to
the nucleus since its size remains relatively constant during the
time of incubation.
During the last years, the possible nuclear compartmentaliza-
tion of glutathione related enzymes such as, glutathione S-
transferase (GST) isoenzymes has inspired various reports
[47,48,49], but the precise function (or functions) of the
glutathione S-transferases in the cell nucleus remains to be
elucidated. Two possible roles have been suggested: biotransfor-
mation of electrophilic compounds, protecting the DNA content,
where the GST catalyzes the conjugation of glutathione to the
xenobiotic compound in a detoxification-related mechanism, and
a possible role in modulating gene expression. How GST may
contribute to this procedure or which is the exact role of this
enzyme in gene regulation is still a question that remains to be
answered. However, we could not find significant changes in GST
activity when cell were treated with DEM or BSO.
The role of nuclear GSH: protective and/or regulatory
We show here and in a previous report [24] that nuclear
glutathiolation changes during the cell cycle and that the depletion
of nuclear GSH changes the pattern of nuclear glutathionylated
proteins. The suggestion that reduced nuclear environment could
protect oxidant sensitive proteins from oxidation [50] could be
confirmed by our results: there was less glutathionilated and more
oxidised proteins when the nuclear GSH was depleted by DEM
(Fig. 8). However, after nuclear GSH increased (Fig. 4B, 72 h) the
glutathionylation of nuclear protiens in DEM treated cells reached
the values of control (Fig. 8A), while the level of protein oxidation
remainedhigh(Fig.8B).Thisreflectstheirreversibleconsequence of
nuclear GSH depletion early in the culture and could account for
the persisting lower growth rate of DEM treated cells (Fig. 1),
despite the important increase in total GSH level. Our study of the
expression of Id2 gave support to this assumption; when the nuclear
glutathione level is high, the expression of this proliferative marker
was also high, while the depletion of nuclear glutathione with DEM
caused the important decrease in the level of this protein, and
consequently, the decrease in the proliferation. On the contrary,
cells treated with BSO maintained their nuclear glutathione level as
well as the high expression of Id2 and normal cell growth.
So, the presence of the high glutathione level in the nucleus
appears to be a prerequisite for the start of the cell proliferation.
Our findings are in line with several other studies aimed to
elucidate the fine redox regulatory mechanisms that lie behind the
correct cell cycle progression. Conour et al. [50], suggested that
the reduction of the intracellular environment as cells progress
from G1 to G2/M phase, as shown in our study, may protect
genomic DNA from oxidative damage upon brake down of the
nuclear envelope. Indeed, one of the assertions in support of this
premise derives from the study of oxidative stress related to
genotoxicity, recently published by Green [35]; oxidative DNA
modifications displayed a negative linear correlation with nuclear
GSH. This is of special importance considering the report of
Menon et al [7] on the necessity of the oxidative event in early G1
phase to allow G1-S transition. Even more, it has recently been
postulated that the restriction of DNA synthesis to the reductive
phase of the cycle in yeast may be an evolutionarily important
mechanism for reducing oxidative damage to DNA during
replication [51], which implies the common mechanism of the
DNA protection during S phase in all eukaryotes.
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reduced than the cytosol (15 mM GSH vs. 11 mM, respectively)
[52,53,54]. An important number of nuclear proteins, including
transcription factors, require a reduced environment tobind to DNA.
More than 62 proteins are involved directly in transcription,
nucleotide metabolism, (de)phosphorylation, or (de)ubiquitinylation,
which are all essential processes for cell cycle progression [50]. For
instance, it appears that, at the onset of cell proliferation in the early
G1 phase, an increase of ROS in the cytoplasm is necessary for the
initiation of the phosphorylation cascade mediated by epidermal
growth factor (EGF) that, subsequently, activates DNA replication
and the cell division ([55]). According to Jang and Surh [56] nuclear
GSH may act as a transcriptional regulator of NF-kB, AP-1, and p53
by altering their nuclear redox state. The transcription factor NF-kB
is an example of distinct redox-sensitive activation and DNA binding
[57]; it is activated by various physiological stimuli known to produce
ROS; on the contrary, to permit DNA binding, similar to Fos, Jun,
and Nrf2, cysteine residue within DNA binding domain must be
reduced. Both processes are guaranteed by the adequate redox state
of the cytosolic and nuclear environment, respectively. Recently
Reddy et al. [58] have shown that Nrf2 deficiency leads to oxidative
stress and DNA lesions, accompanied by impairment of cell-cycle
progression, mainly G(2)/M-phase arrest. Both N-acetylcysteine and
glutathione (GSH) supplementation ablated the DNA lesions and
DNA damage-response pathways in Nrf2(2/2) cells; however only
GSH could rescue the impaired co-localization of mitosis-promoting
factors and the growth arrest. In addition, Toledano et al.[ 5 9 ]f o u n da
redox-dependent shift of oxyR-DNA contacts along genomic DNA,
suggesting a mechanism for differential promoter selection.
High level of GSH in the nucleus could provide protection to the
proteins against the oxidative threat coming from the cytoplasm at
the early phase of cell proliferation [7], and glutathiolation, as it is a
reversible modification, could be just the way. On the other hand,
based on the simplicity of the redox transition from thiol to disulfide
and on the fact that the reversibility was energetically favourable,
Cotgrave IA and Gerdes RG [60] more than 10 years ago have
proposed glutathionylation as a posttranscriptional modification
with the regulative finality. They state that it offers ‘‘a strong
possibility for transducing ‘‘oxidative information’’ from intracellu-
lar oxidants via the GSH redox buffer to individual proteins
containing ‘‘regulatory thiols’’. Also, recently, this posttranslational
modification was proposed as a likely molecular mechanism for
redox dependent signalling mediated by GSH [61]. Thus, high level
of GSH in the nucleus, observed before and at the onset of cell
proliferation, could provide the ‘‘GSH redox buffer’’ necessary for
the progressing of oxidant stimulated mitogenesis.
On the other hand, as according to interesting hypothesis
offered by Bellomo et al. [52] intranuclear accumulation of
glutathione may modulate the thiol/disulfide redox status of
nuclear proteins and control chromatin compacting and decon-
densation. Consequently, our finding that the pattern and level of
glutathiolation of nuclear proteins change during the cell cycle
[24] and with the depletion of nuclear GSH could contribute to
the possible implication of this modification in the control of
chromatin structure dynamics (for review see [62]).
Since its discovery almost a century ago [63], a number of
important functions have been attributed to GSH, however, its
outstanding role in nucleated, but not in prokaryotic cells, remains
unknown. Our results demonstratefor the first time that it is nuclear
GSH levels, and not total cellular glutathione levels, that play a
decisive role in cellular proliferation. Our report underscores the
important role of nuclear glutathione in cell physiology and suggests
that manipulation on nuclear GSH levels could be of paramount
importance during development and cancer.
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